ICD-11 classes
06 Mental, behavioural or neurodevelopmental disorders
Disorders due to substance use or addictive behaviours
Disorders due to substance use
6C4C — Disorders due to use of MDMA or related drugs, including MDA
ICD-11 6C4C — Disorders due to use of MDMA or related drugs, including MDA
Disorders due to use of MDMA or related drugs, including MDA are characterised by the pattern and consequences of MDMA or related drug use. MDMA is methylene-dioxymethamphetamine and is a common drug of abuse in many countries especially among young people. It is predominantly available in tablet form known as ‘ecstasy’. Pharmacologically, MDMA has stimulant and empathogenic properties and these encourage its use among young people for social and other interactions. Considering its wide prevalence in many countries and among many sub-groups of young people, MDMA and Related Drug Dependence and MDMA and Related Drug Withdrawal are comparatively uncommon. Substance-Induced Mental Disorders may arise from its use. Several analogues of MDMA exist, including MDA (methylene-dioxyamphetamine).
The diagnosis includes nothing.
It excludes 1 item.
- Hazardous use of MDMA or related drugs (QE11.6)
Diagnosis with code 6C4C contains 10 clarifying diagnoses:
- 6C4C.0 — Episode of harmful use of MDMA or related drugs, including MDA
- 6C4C.1 — Harmful pattern of use of MDMA or related drugs, including MDA
It contains 3 clarifying diagnoses. - 6C4C.2 — MDMA or related drug dependence, including MDA
It contains 5 clarifying diagnoses. - 6C4C.3 — MDMA or related drug intoxication, including MDA
- 6C4C.4 — MDMA or related drug withdrawal, including MDA
- 6C4C.5 — MDMA or related drug-induced delirium, including MDA
- 6C4C.6 — MDMA or related drug-induced psychotic disorder, including MDA
- 6C4C.7 — Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA
It contains 2 clarifying diagnoses. - 6C4C.Y — Other specified disorders due to use of MDMA or related drugs, including MDA
- 6C4C.Z — Disorders due to use of MDMA or related drugs, including MDA, unspecified